skip to content

Welcome to the MRC Toxicology Unit

The Medical Research Council (MRC) Toxicology Unit is a leading International Research Institute within the School of Biological Sciences, University of Cambridge. The Unit delivers mechanistic toxicology research, pursuing hypothesis-driven toxicological questions with a particular focus on the study of the causal links between exposure to endogenous and exogenous toxicants, molecular initiating events and adverse outcome pathways. The Unit's overall aims are to carry out pioneering research which leads to improved health and to train and mentor the next generation of toxicologists.

 

Professor Anne Willis is Director of the MRC Toxicology Unit.  Anne was appointed as a member of the European Molecular Biology Organisation in 2015, and in 2017 awarded an OBE for services to biomedical sciences and supporting the careers of women scientists.

 

     Professor Anne Willis OBE

News

New method for nutrient-tracing within a microbial community

20 February 2023

Cross-feeding, or the exchange of nutrients between organisms, is fundamental to the diversity and function of microbial communities. However, pinpointing the corresponding donors and receivers to understand more about this nutrient exchange is challenging as amino acids, nucleotides and more are universal across all...

Read more

Scientists uncover new target for Parkinson's disease treatment

30 January 2023

Parkinson’s disease is a complex neurodegenerative disorder, and currently there is no cure. With 1 in 37 people alive today in the UK predicted to be diagnosed with Parkinson’s in their lifetime, finding new ways to diagnose earlier and delay the progression of the disease is urgently needed. Although most cases of...

Read more

Unit researchers part of consortium awarded £8M in funding to enhance the UK’s nucleic acid therapeutics delivery platforms

16 January 2023

We are delighted to share the news that Prof Anne Willis and Dr Ritwick Sawarkar are a part of a consortium that has been awarded £8 million by the Nucleic Acid Therapy Accelerator (NATA) to enhance the UK's nucleic acid therapeutics delivery platforms. The consortium, led by Professor Matthew Wood at the University of...

Read more